跳至主要内容
临床试验/NCT06575660
NCT06575660已完成不适用

Digital Support for Mental Health Intervention in Patients With Inflammatory Bowel Disease

University of Chicago2 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2024年9月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
2
主要终点
Determine the safety of utilizing a GPT-4-powered AI-VR mental health support session in patients with IBD

研究概览

简要总结

This is a small, exploratory study that will investigate using an artificial intelligence (AI) and virtual reality (VR), digital wellness application (app) to deliver a mental health support session in outpatient and hospitalized patients with inflammatory bowel disease (IBD) and co-existing symptoms of mild to moderate anxiety or depression.

The purpose of this study is to explore if a mental health support session using the app is feasible, safe, and acceptable to IBD patients and whether it could possibly help with physical and comorbid psychological symptoms of these patients.

详细描述

The mental health support session is delivered by a virtual reality digital wellness application (app). The app is a Chat GPT-4 powered AI and VR platform called XAIA (eXtended reality Artificially Intelligent Ally). [Chat GPT is an AI program that generates dialogue.] The app is publicly available on the Apple Vision Pro (a VR tool). It was developed by a group of providers, including a psychiatrist, at Cedars-Sinai Medical Center to devise a scalable solution for the increasing demand for mental wellness experiences. The application uses the combination of an AI-powered virtual avatar, named "XAIA," and a VR environment to deliver immersive and personalized mental health support in mixed-reality environments.

This is a mixed method study with primarily a qualitative focus. Patients with IBD who self-report mild to moderate levels of anxiety or depression will be invited to try a single AI-VR mental health support session using the XAIA app. Participant observations, experiences, and opinions of the application will be collected through surveys and semi-structured interviews. Pre- and post- session pain and state anxiety scores will be collected.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18+ years of age
  • Patients with Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)
  • English-speaking
  • Patients with score of 5-14 on General Anxiety Disorder-7 (GAD-7) questionnaire or 5-19 on Patient Health Questionnaire-9 (PHQ-9) within 3 months
  • Able to provide written consent

排除标准

  • Unwilling and/or unable to participate
  • Non-English speakers
  • Self-reported history of severe motion sickness
  • The presence of a facial/head deformity that will prohibit comfortably wearing of a VR headset
  • Legally blind or deaf
  • Having had a seizure in the past year
  • Unable to understand the instructions or to consent to participation in the study.
  • Those who are pregnant

结局指标

主要结局

Determine the safety of utilizing a GPT-4-powered AI-VR mental health support session in patients with IBD

时间窗: Day 1 post-session

Measured by proportion of subjects with at least one adverse event

Determine the patient acceptance of utilizing a GPT-4-powered AI-VR mental health support session in patients with IBD

时间窗: Day 1 post-session

Measured via Session Rating Scale (SRS V.3.0), which is a visual analogue scale that measures self-reported effective therapeutic relationships. Scores range from 0 to 40, with higher scores indicating more effective relationships. Scores are commonly classified as "any score lower than 36 overall, or 9 on any \[of the 4\] scale\[s\], could be a source of concern..."

Determine the feasibility of utilizing a GPT-4-powered AI-VR mental health support session in patients with IBD

时间窗: Day 1 post-session

Measured via a post-session, semi-structured interview

次要结局

  • To characterize any limitations for creating a AI-VR mental health support tool optimally aligned with the needs of patients with IBD(Day 1 post-session)
  • To assess change in pain scores pre- and post-session(Day 1 pre-session; Day 1 post-session)
  • To assess change in mood scores pre- and post-session(Day 1 pre-session; Day 1 post-session)
  • To characterize any potential future improvements for creating a AI-VR mental health support tool optimally aligned with the needs of patients with IBD(Day 1 post-session)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验